Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms

Blood

Volumn 101, Issue 10, 2003, Pages 4140-4147

  Gavins, Felicity N E ^b   Yona, Simon ^b   Kamal, Ahmad M ^b   Flower, Roderick J ^b   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLMETHIONYLVALYLSERYLGLUTAMYLPHENYLALANYLLEUCYLLYSYLGLUTAMINYLALANYLTRY PTOPHYLPHENYLALANYLISOLEUCYLGLUTAMYLASPARAGINYLGLUTAMYLGLUTAMYLGLUTAMINYLGLUTAMY LTYROSYLVALYLGLUTAMINYLTHREONYLVALYLLYSINE; ALPHA CHEMOKINE; ALPHA CHEMOKINE KC; ANNEXIN; FORMIN PEPTIDE RECEPTOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LIPOXIN A; LIPOXIN A RECEPTOR; N TERT BUTYLOXYCARBONYLPHENYLALANYL DEXTRO LEUCYLPHENYLALANYL DEXTRO LEUCYLPHENYLALANINE; RECEPTOR; RECEPTOR BLOCKING AGENT; RNA; UNCLASSIFIED DRUG; FORMYLPEPTIDE RECEPTOR; FPRL1 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; LIPOCORTIN 1; LIPOXIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVITY; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EPITHELIUM; GENE EXPRESSION; IN VIVO STUDY; INHIBITION KINETICS; INJECTION; ISCHEMIA; LEUKOCYTE; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; MESENTERY; MICROCIRCULATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REPERFUSION; ANIMAL; C57BL MOUSE; CROSS BREEDING; GENETICS; HUMAN; INFLAMMATION; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANNEXIN A1; CELL ADHESION; CROSSES, GENETIC; HUMANS; INFLAMMATION; LEUKOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOXIN; RECEPTORS, PEPTIDE;

EID: 0037588978     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-11-3411     Document Type: Article

References (47)

1. Gallin JI, Goldstein IM, Snyderman R. Overview. In: Gallin JI, Goldstein IM, eds. Inflammation: Basic Principles and Clinical Correlates. 2nd ed. New York, NY: Raven Press; 1992:1-4.
2. Panés J, Perry M, Granger DN. Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention. Br J Pharmacol. 1999;126:537-550.
3. Savill J. Apoptosis in resolution of inflammation. J Leukoc Biol. 1997;61:375-380.
4. Cronstein BN, Naime D, Ostad E. The antiinflammatory mechanism of methotreaxate: increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest. 1993;92:2675-2682.
5. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol. 2001;2:612-619.
6. Goulding NJ, Godolphin JL, Sharland PR, et al. Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone. Lancet. 1990;335:1416-1418.
7. 2+-dependent membrane fusion. J Clin Invest. 1992;90:537-544.
8. Perretti M, Croxtall JD, Wheller SK, et al. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat Med. 1996;22:1259-1262.
9. Perretti M, Wheller SK, Choudhury Q, Croxtall JD, Flower RJ. Selective inhibition of neutrophil function by a peptide derived from lipocortin 1 N-terminus. Biochem Pharmacol. 1995;50:1037-1042.
10. Walther A, Riehemann K, Gerke V. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol Cell. 2000;5:831-840.
11. Perretti M, Ahluwalia A, Harris JG, Goulding NJ, Flower RJ. Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse: a qualitative comparison with an anti-CD11b monoclonal antibody. J Immunol. 1993;151:4306-4314.
12. Mancuso F, Flower RJ, Perretti M. Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule: involvement of endogenous lipocortin 1. J Immunol. 1995;155:377-386.
13. Perretti M. Lipocortin 1 and chemokine modulation of granulocyte and monocyte accumulation in experimental inflammation. Gen Pharmacol. 1998;31:545-552.
14. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol. 2002;23:541-548.
15. Gao J-L, Chen H, Filie JD, Kozak CA, Murphy PM. Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. Genomics. 1998;51:270-276.
16. Gao JL, Wynn TA, Chang Y, et al. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med. 1997;185:1959-1968.
17. Perretti M, Getting SJ, Solito E, Murphy PM, Gao JL. Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics. Am J Pathol. 2001;158:1969-1973.
18. 4 receptor. Nat Med. 2002;8:1296-1302.
19. Cuzzocrea S, Tailor A, Zingarelli B, et al. Lipocortin 1 protects against splanchnic artery occlusion and reperfusion injury by affecting neutrophil migration. J Immunol. 1997;159:5089-5097.
20. Gao JL, Lee EJ, Murphy PM. Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J Exp Med. 1999;189:657-662.
21. 1 receptor expression and leukocyte trafficking across mouse mesenteric postcapillary venules. J Exp Med. 2000;192:367-380.
22. Baller D, Bretschneider HJ, Hellige G. A critical look at currently used indirect indices of myocardial oxygen consumption. Basic Res Cardiol. 1981;76:163-181.
23. Bienvenu K, Granger DN. Molecular determinants of shear rate-dependent leukocyte adhesion in postcapillary venules. Am J Physiol. 1993;264:H1504-H1508.
24. Kurose I, Wolf R, Grisham MB, et al. Microvascular responses to inhibition of nitric oxide procution: role of active oxidants. Circ Res. 1995;76:30-39.
25. Rumbaut RE, Harris NR, Sial AJ, Huxley VH, Granger DN. Leakage responses to L-NAME differ with the fluorescent dye used to label albumin. Am J Physiol. 1999;276:H333-H339.
26. Lim LH, Solito E, Russo-Marie F, Flower RJ, Perretti M. Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc Natl Acad Sci U S A. 1998;95:14535-14539.
27. La M, D'Amico M, Bandiera S, et al. Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action. FASEB J. 2001;15:2247-2256.
28. 4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med. 1997;185:1693-1704.
29. Harris JG, Flower RJ, Perretti M. Alteration of neutrophil trafficking by a lipocortin 1 N-terminus peptide. Eur J Pharmacol. 1995;279:149-157.
30. 4 receptor interaction. Biochemistry. 1995;34:16678-16686.
31. Clish CB, O'Brien JA, Gronert K, et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc Natl Acad Sci U S A. 1999;96:8247-8252.
32. 4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J Exp Med. 2000;191:1197-1208.
33. Dalpiaz A, Ferretti ME, Pecoraro R, et al. Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects. Biochim Biophys Acta. 1999;1432:27-39.
34. Dalpiaz A, Ferretti ME, Vertuani G, et al. C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor. Eur J Pharmacol. 2002;436:187-196.
35. Doherty NS, Griffiths RJ, Hakkinen JP, Scampoli DN, Milici AJ. Post-capillary venules in the "milky spots" of the greater omentum are the major site of plasma protein and leukocyte extravasation in rodent models of peritonitis. Inflamm Res. 1995;44:169-177.
36. Takemori N, Hirai K, Onodera R, Saito N, Namiki M. Light and electron microscopic study of omental milky spots in New Zealand black mice, with special reference to the extramedullary hematopoiesis. Anat Embryol (Berl). 1994;189:215-226.
37. He R, Tan L, Browning DD, Wang JM, Ye RD. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor. J Immunol. 2000;165:4598-4605.
38. Strausbaugh HJ, Rosen SD. A potential role for annexin 1 as a physiologic mediator of glucocorticoid-induced I-selectin shedding from myeloid cells. J Immunol. 2001;166:6294-6300.
39. Gronert K, Martinsson-Niskanen T, Ravasi S, Chiang N, Serhan CN. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. Am J Pathol. 2001;158:3-9.
40. Liang TS, Wang JM, Murphy PM, Gao JL. Serum amyloid A is a chemotactic agonist at FPR2, a low-affinity N-formylpeptide receptor on mouse neutrophils. Biochem Biophys Res Commun. 2000;270:331-335.
41. Rabb H, O'Meara YM, Maderna P, Coleman P, Brady HR. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int. 1997;51:1463-1468.
42. Scalia R, Gefen J, Petasis NA, Serhan CN, Lefer AM. Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. Proc Natl Acad Sci U S A. 1997;94:9967-9972.
43. Srikrishna G, Panneerselvam K, Westphal V, et al. Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. J Immunol. 2001;166:4678-4688.
44. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121-127.
45. Bozic CR, Kolakoswki LF, Gerard NP, et al. Expression and biological characterization of the murine chemokine KC. J Immunol. 1995;154:6048-6057.
46. Harris JG, Flower RJ, Watanabe K, et al. Relative contribution of the selectins in the neutrophil recruitment caused by the chemokine cytokine-induced neutrophil chemoattractant (CINC). Biochem Biophys Res Commun. 1996;221:692-696.
47. Hatanaka K, Katori M. Detachment of polymorphonuclear leukocytes adhered on venular endothelial cells. Microcirc Ann. 1992;8:129-130.